Inhibikase Therapeutics
(NASDAQ:IKT)
$2.00
-0.10[-4.76%]
At close: Apr 19
$2.00
0[0.00%]
After Hours: 5:15PM EDT

Inhibikase Therapeutics Stock (NASDAQ:IKT), Quotes and News Summary

Inhibikase Therapeutics Stock (NASDAQ: IKT) stock price, news, charts, stock research, profile.

Open$2.120
Close$2.040
Volume / Avg.52.727K / 136.152K
Day Range2.020 - 2.130
52 Wk Range0.790 - 4.351
Market Cap$13.134M
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
37
Short Interest
0.36%
Days to Cover1
-%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trend
2
Mar
Buy
Hold
Sell
Strong Sell
Analyst Rating
12345
3.5
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell
About Inhibikase Therapeutics Inc
Sector
Health Care
Industry
Biotechnology
Inhibikase Therapeutics Inc is a a clinical-stage pharmaceutical company developing protein kinase i...
Show More

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
IKT
ERNA

FAQ

Q

How do I buy Inhibikase Therapeutics (IKT) stock?

A

You can purchase shares of Inhibikase Therapeutics (NASDAQ: IKT) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Inhibikase Therapeutics's (IKT) competitors?

Q

What is the target price for Inhibikase Therapeutics (IKT) stock?

A

The latest price target for Inhibikase Therapeutics (NASDAQ: IKT) was reported by HC Wainwright & Co. on Thursday, March 7, 2024. The analyst firm set a price target for 27.00 expecting IKT to rise to within 12 months (a possible 1250.00% upside). 5 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Inhibikase Therapeutics (IKT)?

A

The stock price for Inhibikase Therapeutics (NASDAQ: IKT) is $2 last updated April 19, 2024 at 5:15 PM EDT.

Q

Does Inhibikase Therapeutics (IKT) pay a dividend?

A

There are no upcoming dividends for Inhibikase Therapeutics.

Q

When is Inhibikase Therapeutics (NASDAQ:IKT) reporting earnings?

A

Inhibikase Therapeutics’s Q1 earnings are confirmed for Monday, May 13, 2024.

Q

Is Inhibikase Therapeutics (IKT) going to split?

A

There is no upcoming split for Inhibikase Therapeutics.

Q

What sector and industry does Inhibikase Therapeutics (IKT) operate in?

A

Inhibikase Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch